piracetam has been researched along with Complex Partial Epilepsy in 21 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Herein, we describe two young men with epilepsy who experienced severe loss of libido and anhedonia after levetiracetam intake." | 7.78 | Levetiracetam-associated loss of libido and anhedonia. ( Bramanti, P; Calabrò, RS; Italiano, D; Militi, D, 2012) |
| "A 64-year-old patient with symptomatic epilepsy developed thrombocytopenia during treatment with levetiracetam (LEV)." | 7.74 | Thrombocytopenia during levetiracetam therapy. ( Meschede, A; Runge, U; Sabolek, M, 2008) |
| "Effects of NEF on fully amygdala-kindled seizures and development of amygdala-kindled seizures were investigated in rats and compared with those of levetiracetam (LEV), a pyrrolidone-type antiepileptic drug (AED)." | 7.73 | Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats. ( Kasai, Y; Kinoshita, M; Kitano, Y; Komiyama, C; Makino, M; Sakurada, S; Takasuna, K; Takazawa, A; Yamauchi, T; Yamazaki, O, 2005) |
| " Mean dosage was 1,643 mg/day (range 500-4,000)." | 5.35 | Intravenous levetiracetam for epileptic seizure emergencies in older people. ( Beyenburg, S; Maraite, N; Reuber, M, 2009) |
| " Herein, we describe two young men with epilepsy who experienced severe loss of libido and anhedonia after levetiracetam intake." | 3.78 | Levetiracetam-associated loss of libido and anhedonia. ( Bramanti, P; Calabrò, RS; Italiano, D; Militi, D, 2012) |
| "A 64-year-old patient with symptomatic epilepsy developed thrombocytopenia during treatment with levetiracetam (LEV)." | 3.74 | Thrombocytopenia during levetiracetam therapy. ( Meschede, A; Runge, U; Sabolek, M, 2008) |
| "Effects of NEF on fully amygdala-kindled seizures and development of amygdala-kindled seizures were investigated in rats and compared with those of levetiracetam (LEV), a pyrrolidone-type antiepileptic drug (AED)." | 3.73 | Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats. ( Kasai, Y; Kinoshita, M; Kitano, Y; Komiyama, C; Makino, M; Sakurada, S; Takasuna, K; Takazawa, A; Yamauchi, T; Yamazaki, O, 2005) |
| " Mean dosage was 1,643 mg/day (range 500-4,000)." | 1.35 | Intravenous levetiracetam for epileptic seizure emergencies in older people. ( Beyenburg, S; Maraite, N; Reuber, M, 2009) |
| "Levetiracetam was given alone or in combination with 7-nitroindazole, a preferential inhibitor of neuronal nitric oxide synthase, or with L: -arginine, the precursor of nitric oxide synthesis." | 1.35 | In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugs. ( Carletti, F; D'Agostino, S; Ferraro, G; Lonobile, G; Rizzo, V; Sardo, P, 2009) |
| "Levetiracetam-treated patients commonly report daytime drowsiness, fatique, asthenia and decreasing of motor activity." | 1.34 | Comparison of motor activity and sleep in patients with complex partial seizures on levetiracetam treatment and a group of healthy subjects. ( Yilmaz, H, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (80.95) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luszczki, JJ | 1 |
| Patrzylas, P | 1 |
| Zagaja, M | 1 |
| Andres-Mach, M | 1 |
| Zaluska, K | 1 |
| Kondrat-Wrobel, MW | 1 |
| Szpringer, M | 1 |
| Chmielewski, J | 1 |
| Florek-Luszczki, M | 1 |
| Tanaka, S | 1 |
| Tanaka, T | 1 |
| Shahbaz, S | 1 |
| Sivamani, RK | 1 |
| Konia, T | 1 |
| Burrall, B | 1 |
| Belcastro, V | 1 |
| Costa, C | 1 |
| Striano, P | 1 |
| Huang, CW | 1 |
| Pai, MC | 1 |
| Tsai, JJ | 1 |
| Beyenburg, S | 1 |
| Reuber, M | 1 |
| Maraite, N | 1 |
| Carota, A | 1 |
| Novy, J | 1 |
| Rossetti, AO | 1 |
| Cholongitas, E | 1 |
| Karatzi, C | 1 |
| Spyrou, S | 1 |
| Georgousaki, C | 1 |
| Dasenaki, M | 1 |
| Sardo, P | 1 |
| D'Agostino, S | 1 |
| Rizzo, V | 1 |
| Carletti, F | 1 |
| Lonobile, G | 1 |
| Ferraro, G | 1 |
| Rosenzweig, I | 1 |
| Valentin, A | 1 |
| Brex, PA | 1 |
| Elwes, RD | 1 |
| Alarcon, G | 1 |
| Calabrò, RS | 1 |
| Italiano, D | 1 |
| Militi, D | 1 |
| Bramanti, P | 1 |
| Leppik, IE | 1 |
| Biton, V | 1 |
| Sander, JW | 1 |
| Wieser, HG | 1 |
| Kitano, Y | 1 |
| Komiyama, C | 1 |
| Makino, M | 1 |
| Kasai, Y | 1 |
| Takasuna, K | 1 |
| Kinoshita, M | 1 |
| Yamazaki, O | 1 |
| Takazawa, A | 1 |
| Yamauchi, T | 1 |
| Sakurada, S | 1 |
| Allegaert, K | 1 |
| Lewi, L | 1 |
| Naulaers, G | 1 |
| Lagae, L | 1 |
| Yilmaz, H | 1 |
| Knake, S | 1 |
| Gruener, J | 1 |
| Hattemer, K | 1 |
| Klein, KM | 1 |
| Bauer, S | 1 |
| Oertel, WH | 1 |
| Hamer, HM | 1 |
| Rosenow, F | 1 |
| Wurpts, G | 1 |
| Ott, H | 1 |
| Schlüter, A | 1 |
| Häusler, M | 1 |
| Thacker, AK | 1 |
| Misra, P | 1 |
| Gupta, PP | 1 |
| Jackson, MJ | 1 |
| Meschede, A | 1 |
| Runge, U | 1 |
| Sabolek, M | 1 |
| Doheny, HC | 1 |
| Whittington, MA | 1 |
| Jefferys, JG | 1 |
| Patsalos, PN | 1 |
1 review available for piracetam and Complex Partial Epilepsy
| Article | Year |
|---|---|
Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combina | 2003 |
1 trial available for piracetam and Complex Partial Epilepsy
| Article | Year |
|---|---|
Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Cognition Disorders; Drug Therapy, Combination; Epilepsies, Part | 2008 |
19 other studies available for piracetam and Complex Partial Epilepsy
| Article | Year |
|---|---|
Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice.
Topics: Acetamides; Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Benzodiazepines; Clobaz | 2017 |
Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
Topics: Adult; Anticonvulsants; Benzodiazepines; Clobazam; Drug Therapy, Combination; Epilepsies, Partial; E | 2013 |
A case of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) related to rufinamide.
Topics: Anti-Inflammatory Agents; Anticonvulsants; Child; Drug Hypersensitivity Syndrome; Epilepsy, Complex | 2013 |
Levetiracetam-associated hyponatremia.
Topics: Aged; Anticonvulsants; Epilepsy, Complex Partial; Humans; Hyponatremia; Levetiracetam; Male; Piracet | 2008 |
Intravenous levetiracetam for epileptic seizure emergencies in older people.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Drug Tolerance; Emergencies; Epilepsy; Epilepsy, Complex P | 2009 |
Symptomatic complex partial status epilepticus manifesting as utilization behavior of a mobile phone.
Topics: Anticonvulsants; Benzodiazepines; Brain Neoplasms; Cell Phone; Clobazam; Electroencephalography; Epi | 2009 |
Linezolid-induced complex partial seizures in a patient with epilepsy.
Topics: Acetamides; Aged; Anti-Infective Agents; Epilepsy; Epilepsy, Complex Partial; Humans; Levetiracetam; | 2009 |
In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugs.
Topics: Animals; Anticonvulsants; Arginine; Dentate Gyrus; Disease Models, Animal; Dose-Response Relationshi | 2009 |
Face-related ictal hallucinations and illusions and reflex-type phenomena.
Topics: Adult; Anticonvulsants; Cerebral Cortex; Electroencephalography; Epilepsy, Complex Partial; Face; Fe | 2009 |
Levetiracetam-associated loss of libido and anhedonia.
Topics: Adult; Anhedonia; Anticonvulsants; Brain; Electroencephalography; Epilepsies, Myoclonic; Epilepsy, C | 2012 |
Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
Topics: Administration, Oral; Amygdala; Animals; Anticonvulsants; Behavior, Animal; Disease Models, Animal; | 2005 |
Levetiracetam pharmacokinetics in neonates at birth.
Topics: Amniotic Fluid; Anticonvulsants; Epilepsy, Complex Partial; Female; Fetal Blood; Half-Life; Humans; | 2006 |
Comparison of motor activity and sleep in patients with complex partial seizures on levetiracetam treatment and a group of healthy subjects.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Disorders of Excessive Somnolence; Electroencephalography; | 2007 |
Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticonvulsants; Benzodiazepines; Dose-Respons | 2008 |
[DRESS syndrome after carbamazepine].
Topics: Anticonvulsants; Carbamazepine; Child; Drug Eruptions; Eosinophilia; Epilepsy, Complex Partial; Fema | 2007 |
Exacerbations of seizures by levetiracetam.
Topics: Acute Disease; Adult; Dose-Response Relationship, Drug; Epilepsy; Epilepsy, Complex Partial; Female; | 2008 |
Should we accept the status quo? Time for new trials in status epilepticus.
Topics: Adult; Anticonvulsants; Electroencephalography; Epilepsy, Complex Partial; Humans; Infusions, Intrav | 2008 |
Thrombocytopenia during levetiracetam therapy.
Topics: Anticonvulsants; Epilepsy, Complex Partial; Female; Humans; Levetiracetam; Middle Aged; Piracetam; T | 2008 |
A comparison of the efficacy of carbamazepine and the novel anti-epileptic drug levetiracetam in the tetanus toxin model of focal complex partial epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy, Complex Partial; Levetiracetam; Male; Piracetam; | 2002 |